PATENT CLAIM ANALYSIS

Application Number: 16103375
Application Type: Utility
Filing Date: 2018-08
Publication Date: 2018-12
Patent Classification: ["514", "253130"]

Abstract:
The disclosure provides compounds of Formulae (I)-(IX). The disclosed compounds are capable of inhibiting a mammalian SHMT. Compounds of the disclosure have numerous uses, such as for treatment of cancer or autoimmue disorders.

Claim (Index 12):
The method according to  claim 1 , wherein:\n R 0  is \u2014H; one of R 1  and R 2  is substituted or unsubstituted alkenyl, or substituted or unsubstituted alkynyl; the other is independently selected from the group consisting of \u2014H, halogen, hydroxyl, nitro, nitrile, \u2014OR 11 , substituted or unsubstituted alkyl, substituted or unsubstituted alkenyl, substituted or unsubstituted alkynyl, substituted or unsubstituted haloalkyl, or substituted or unsubstituted haloalkoxy; R 3  is selected from the group consisting of isopropyl, cyclopropyl, and cyclobutyl; R 4  is methyl or isopropyl; and R 5 , R 6  and R 7  are each independently selected from the group consisting of \u2014H, alkyl, phenyl, and \u2014COCH 3 .

Metadata:
- Claim Count in Document: 17.0
- Percentile: 96.0
- Lexical Diversity: 1.30303
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15705200', '15552442', '14346359', '13891067', '13227130']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8156146447565943
- 35 USC 102 Novelty (BERT): 0.7180062659495993
- Combined Prediction Score: 0.8058538068758948
- Mean Citation Score: 448.057326
- Max Citation Score: 794.0231
- Similarity Product: 764.726926002419

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test